Hepagene 雅创医药
Hepagene.com
雅创医药
ABOUT HEPAGENE
Non-alcoholic Steatohepatitis (NASH)
Chronic Hepatitis B Infection (HBV)
PIPELINE
Hepagene Therapeutics, Inc, Announces Dosing of First Healthy Subject in a Phase I Study of HPG1860 for NASH
About HPG1860
About NASH
About Hepagene Therapeutics, Inc
MANAGEMENT TEAM
ABOUT
MANAGEMENT TEAM
INVESTORS
THERAPEUTIC FOCUS
PIPELINE
NEWS
CAREERS
CONTACT US
CONTACT US
For further information, please contact:
Ms. Tao
：investor@hepagene.com
